Browse Articles
Discover research articles across all indexed journals
Click-polymerized polyenamine membranes for efficient lithium extraction
Dual-interface stabilization of low-iridium anodes for durable proton exchange membrane water electrolysis
Abstract The durability and cost of iridium-based anodes remain key challenges for high-current density operation of proton exchange membrane water electrolyzers. Here, we report a dual-interface stabilization strategy based on atomic layer deposition of TiO 2 onto IrO 2 catalysts. The resulting anodes sustain operation at 3.0 A cm −2 for 2600 h with near-zero voltage degradation at an iridium loading of 0.4 mg cm −2 , whereas bare IrO 2 exhibits continuous voltage decay over 1000 h at a rate of 31.5 mV kh −1 . Combined experimental characterization and theoretical calculations reveal that interfacial Ti-O-Ir coupling suppresses Ir over-oxidation and dissolution, while the TiO 2 -coated surface strengthens ionomer-catalyst interactions and preserves mass-transport pathways during prolonged operation. This strategy is fully compatible with roll-to-roll manufacturing, enabling industrially scalable implementation. This interfacial engineering approach offers a generalizable design principle for extending electrolyzer lifetime and reducing precious-metal loading across diverse electrochemical energy conversion technologies.
Widespread controls of precipitation sensitivity on drought recovery of global forests
North Pacific meltwater weakens the Atlantic Meridional Overturning Circulation and preconditions Heinrich Stadial 1
Abstract Heinrich Stadials provide insights into a potential future weakening of the Atlantic Meridional Overturning Circulation (AMOC), yet the mechanisms driving AMOC weakening during these intervals remain elusive. While Heinrich Stadials are associated with iceberg-discharge events over the North Atlantic (i.e., Heinrich events), AMOC weakening is known to precede Heinrich events. Here we run freshwater hosing experiments to show that contemporaneous Northeast Pacific iceberg-discharge events (i.e., Siku events), which consistently occur at the onsets of Heinrich Stadials, could trigger AMOC weakening by transporting freshwater to the North Atlantic deepwater formation regions. This initial weakening may subsequently be amplified by further meltwater release from the British and Laurentide Ice Sheets, induced by stepwise subsurface warming in the northeastern and northern North Atlantic. Our findings suggest that Siku events may have played a critical role in preconditioning the North Atlantic for Heinrich events, underscoring the interconnected nature of the global ocean–cryosphere system.
A multi-fidelity tabular prior-data fitted network model for accurate prediction and uncertainty quantification
Ancient plume-reinforced lithosphere modulates present-day crustal fluid migration and deformation
CSF1R regulates monocyte subset differentiation and intracellular metabolism
Abstract Monocytes are key circulating effectors of vascular homeostasis, innate immunity and inflammation. Following their generation in mouse bone marrow, classical (Ly6C high ) monocytes are mobilized into the blood circulation where they mature into non-classical (Ly6C low ) patrolling monocytes or are recruited into peripheral tissues where they differentiate into tissue resident or inflammatory macrophages. Monocytes and macrophages express CSF1R (CD115), the receptor for lineage-specific growth factors CSF1 and IL-34. Here, we report that acute CSF1R blockade or genetic deletion negatively interferes with monocyte intracellular metabolism and reduces blood Ly6C low monocytes in part by blunting differentiation of Ly6C high monocytes. Based upon lineage-specific deletion of Glutamine-Fructose-6-Phosphate Transaminase 1 (GFPT1), the hexosamine biosynthetic pathway (HBP) is identified as an important regulator of CSF1R expression and monocyte subsets. Inhibition of receptor tyrosine kinases CSF1R and FLT3 rewires and partially impairs metabolic activity in human monocytes. Our findings provide insights into the link between CSF1R signaling, metabolic regulation, and monocyte survival and differentiation.
CAF-derived PAI-1 serves as an EGFR ligand and fuels KRAS-mutant pancreatic cancer
Glutamatergic signaling underlies brain structural organization for mathematical and reading abilities in children
Proton shuttling at electrochemical interfaces under alkaline hydrogen evolution
Specificity and exon target space of splicing modifying compounds
Abstract Modulation of splicing is an established therapeutic strategy with clinical applications and potential to target specific exons to influence gene expression. Small-molecule splicing modifiers such as Risdiplam and Branaplam induce inclusion of exons typically skipped due to weak $${5}^{{\prime} }$$ 5 ′ splice sites. Risdiplam preferentially induces exons with an N −3 G −2 A −1 sequence at the $${3}^{{\prime} }$$ 3 ′ exon end, whereas Branaplam favors A −3 G −2 A −1 -ending exons. However, determinants of specificity remain unclear, as many motif-matching exons are not induced. Here, we investigate the molecular basis of splicing-modulator specificity. Using biochemical assays, transcriptome analyses, and genetic perturbations, we identify sequence-dependent features that determine exon responsiveness to splicing-modulator induction. We further demonstrate that specificity can be reprogrammed through manipulation of U1 snRNA. These findings refine the determinants of splicing-modulator target space and may support identification of additional target exons and compounds.
Electric field tunable coupling strength and quantum metric hot spots in a moiré flatband superconductor
Closed-loop readout of anterior insula high-gamma activity steers value-based decisions
ZNF689 loss impairs homologous recombination sensitizing triple-negative breast cancer to combined PARP and PD-L1 inhibition
Programmable memtransistor array with temporal dynamics modulation for efficient time-series data processing
Cryo-EM structure of African horse sickness virus VP2 receptor-binding protein enables nanoparticle vaccine design
Ridge catalysis unlocking water oxidation activity of pentlandite
Personalized neoantigen-pulsed autologous dendritic cells in newly-diagnosed glioblastoma: a phase Ib trial
Abstract Newly-diagnosed glioblastoma (nGBM) remains a significant unmet need with limited therapeutic options. Here, we present the results of a single-arm, open-label phase 1b trial on neoantigen-pulsed autologous dendritic cells (ZSNeo-DC) as an adjuvant treatment for nGBM. The primary endpoint was safety, as assessed by the incidence and severity of adverse events (AEs). Eleven patients with nGBM received intradermal administration of ZSNeo-DC following surgery and standard radio-chemotherapy. Treatment was well tolerated, with AEs predominantly grade 1 or 2; only two grade-1/2 febrile AEs were recorded as treatment-related. Secondary endpoint analysis showed that median progression-free survival (PFS) was 16.2 months, median overall survival (OS) was not reached, and 12-month OS rate was 100% from surgery. A range of 1.9- to 284.7-fold (median: 7.2-fold) and 0.7- to 507.0-fold (median: 10.3-fold) increase of peripheral neoantigen-specific immune response (NSIR) was observed respectively after the 3 rd and 5 th vaccination. Following vaccination, both the activated-to-exhausted ratio of effector/central memory T cells and the clonal evenness of the T cell receptor repertoire increased significantly in peripheral blood; these parameters positively correlated with NSIR and PFS. Overall, ZSNeo-DC exhibits a favorable safety profile and preliminary efficacy signals in nGBM, supporting phase 2 evaluation in expanded cohorts. Trial number: NCT04968366.
Ectomesenchyme contributes to epidermal stem cell formation through mesenchymal-to-epithelial transition
Abstract Cutaneous development is initiated by crosstalk between non-neural ectodermal epithelium and underlying mesenchymal cells. Recent studies have shown that some mesenchymal cells contribute to keratinocyte regeneration in injured skin. However, whether mesenchymal cells contribute to keratinocyte formation in physiologically normal skin remains unclear. Here we show, using lineage tracing, single-cell transcriptome and epigenome analyses of mouse skin, that the interfollicular epidermis consists largely of mesenchymal-lineage cells. Further lineage-tracing and live-imaging analysis of mouse embryos indicate that these mesenchymal-lineage epidermal progenitor cells arise from ectomesenchyme and contribute to the surface ectoderm through a mesenchymal-to-epithelial transition-like process between embryonic days 8.5 and 9.5. We also establish human induced pluripotent stem cell-derived ectomesenchyme and demonstrate that it generates p63-expressing keratinocytes. These data reveal a previously unappreciated contribution of ectomesenchyme to cutaneous development and provide insight into skin diseases involving epidermal mosaicism.